lodoco Drug Patent Profile
✉ Email this page to a colleague
When do Lodoco patents expire, and what generic alternatives are available?
Lodoco is a drug marketed by Agepha Pharma Fz and is included in one NDA. There are ten patents protecting this drug.
This drug has seventy-eight patent family members in twenty-five countries.
The generic ingredient in LODOCO is colchicine. There are sixteen drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the colchicine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Lodoco
A generic version of lodoco was approved as colchicine by AMNEAL PHARMS on September 28th, 2016.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for lodoco?
- What are the global sales for lodoco?
- What is Average Wholesale Price for lodoco?
Summary for lodoco
International Patents: | 78 |
US Patents: | 10 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Clinical Trials: | 2 |
Drug Prices: | Drug price information for lodoco |
What excipients (inactive ingredients) are in lodoco? | lodoco excipients list |
DailyMed Link: | lodoco at DailyMed |
![lodoco drug patent expirations Drug patent expirations by year for lodoco](/p/graph/s/t/lodoco-patent-expirations.png)
![Drug Prices for lodoco](/p/graph/drug-price/lodoco.png)
Recent Clinical Trials for lodoco
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Texas Southwestern Medical Center | Phase 2 |
Ottawa Heart Institute Research Corporation | Phase 3 |
Canadian Institutes of Health Research (CIHR) | Phase 3 |
Pharmacology for lodoco
Drug Class | Alkaloid |
Mechanism of Action | Cytochrome P450 3A4 Inhibitors P-Glycoprotein Interactions |
US Patents and Regulatory Information for lodoco
lodoco is protected by eleven US patents.
Patents protecting lodoco
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: A METHOD OF TREATING CARDIOVASCULAR DISEASE
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: A METHOD OF TREATING AND/OR REDUCING THE RISK OF A CARDIOVASCULAR EVENT; ACUTE CORONARY SYNDROME, OUT-OF-HOSPITAL CARDIAC ARREST, AND/OR NONCARDIOEMBOLIC ISCHEMIC STROKE
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: A METHOD FOR TREATING AND/OR REDUCING THE RISK OF A CARDIOVASCULAR EVENT
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: A METHOD OF TREATING AND/OR REDUCING THE RISK OF INFLAMMATION, ATHEROSCLEROTIC VASCULAR DISEASE, AND CHOLESTEROL CRYSTAL INDUCED INFLAMMATION WITHIN ATHEROSCLEROTIC PLAQUES
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: A METHOD FOR TREATING AND/OR REDUCING THE RISK OF A CARDIOVASCULAR EVENT
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: A METHOD FOR TREATING AND/OR REDUCING THE RISK OF A CARDIOVASCULAR EVENT
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: A METHOD FOR TREATING AND/OR REDUCING THE RISK OF ACUTE MYOCARDIAL INFARCTION
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: METHOD FOR REDUCING A RISK OF AT LEAST ONE CARDIOVASCULAR EVENT
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: METHOD FOR REDUCING A COMPOSITE ENDPOINT RISK OF MYOCARDIAL INFARCTION (MI), STROKE, CORONARY REVASCULARIZATION, UNSTABLE ANGINA REQUIRING HOSPITALIZATION, CARDIAC ARREST, AND CARDIOVASCULAR DEATH
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: METHOD FOR REDUCING ACUTE MYOCARDIAL INFARCTION RISK
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: METHOD OF TREATING AND/OR REDUCING THE RISK OF A CARDIOVASCULAR EVENT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Agepha Pharma Fz | LODOCO | colchicine | TABLET;ORAL | 215727-001 | Jun 16, 2023 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Agepha Pharma Fz | LODOCO | colchicine | TABLET;ORAL | 215727-001 | Jun 16, 2023 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Agepha Pharma Fz | LODOCO | colchicine | TABLET;ORAL | 215727-001 | Jun 16, 2023 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Agepha Pharma Fz | LODOCO | colchicine | TABLET;ORAL | 215727-001 | Jun 16, 2023 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Agepha Pharma Fz | LODOCO | colchicine | TABLET;ORAL | 215727-001 | Jun 16, 2023 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Agepha Pharma Fz | LODOCO | colchicine | TABLET;ORAL | 215727-001 | Jun 16, 2023 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for lodoco
See the table below for patents covering lodoco around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Hungary | E056810 | ⤷ Sign Up | |
European Patent Office | 3964205 | TRAITEMENT OU PRÉVENTION D'ÉVÉNEMENTS CARDIOVASCULAIRES (TREATMENT OR PREVENTION OF CARDIOVASCULAR EVENTS) | ⤷ Sign Up |
South Africa | 201507723 | SUSTAINED-RELEASE FORMULATIONS OF COLCHICINE AND METHODS OF USING SAME | ⤷ Sign Up |
Denmark | 2986280 | ⤷ Sign Up | |
South Korea | 20240074883 | 콜히친 유도체의 투여를 통한 심혈관성 병태의 치료 또는 예방 (TREATMENT OR PREVENTION OF CARDIOVASCULAR EVENTS VIA THE ADMINISTRATION OF A COLCHICINE DERIVATIVE) | ⤷ Sign Up |
Eurasian Patent Organization | 201501024 | СОСТАВЫ С ЗАМЕДЛЕННЫМ ВЫСВОБОЖДЕНИЕМ, СОДЕРЖАЩИЕ КОЛХИЦИН, И СПОСОБЫ ИХ ПРИМЕНЕНИЯ | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |